Olympus (FRA:OLY1) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


FRA:OLY1 Olympus Corp FRA:OLY1
82 GF Score
Price €9.06
GF Value €13.88
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Olympus's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


FRA:OLY1 vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Olympus's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Olympus's Margin of Safety % (DCF FCF Based) falls into.


FRA:OLY1
82GF Score
Olympus Corp FRA:OLY1
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Olympus (FRA:OLY1) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of €9.06 is trading 34.8% below its estimated GF Value™ of €13.88. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for FRA:OLY1:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €13.88 vs. price of €9.06 (34.8% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the FRA:OLY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
82GF Score

Get the complete analysis for FRA:OLY1

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.06
Price
€13.88
GF Value